Our in vitro data further support the negative association between fetuin-A and signature inflammatory cytokines such as TNF-α, IL-1-β, and IFN-γ and thus rule out the possible fetuin-A suppressive effects of the antidiabetic and antihypertensive therapy in T2D patients. This evidence concerns the gene IFNG and type 2 diabetes mellitus.